Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non‐acral nevus‐associated melanoma in situ: An institutional experience and meta‐analysis.

MLA

Bui, Chau M., et al. “Clinical Implication of PRAME Immunohistochemistry in Differentiating Melanoma in Situ and Dysplastic Nevus in Non‐acral Nevus‐associated Melanoma in Situ: An Institutional Experience and Meta‐analysis.” Journal of Cutaneous Pathology, vol. 51, no. 10, Oct. 2024, pp. 783–89. EBSCOhost, https://doi.org/10.1111/cup.14671.

APA

Bui, C. M., Vuong, H. G., Le, M., D’Angelo, J., Mannava, K., & Smoller, B. R. (2024). Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non‐acral nevus‐associated melanoma in situ: An institutional experience and meta‐analysis. Journal of Cutaneous Pathology, 51(10), 783–789. https://doi.org/10.1111/cup.14671

Chicago

Bui, Chau M., Huy Gia Vuong, Minh‐Khang Le, Josephine D’Angelo, Kathleen Mannava, and Bruce R. Smoller. 2024. “Clinical Implication of PRAME Immunohistochemistry in Differentiating Melanoma in Situ and Dysplastic Nevus in Non‐acral Nevus‐associated Melanoma in Situ: An Institutional Experience and Meta‐analysis.” Journal of Cutaneous Pathology 51 (10): 783–89. doi:10.1111/cup.14671.